Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 108.5 EUR 1.21% Market Closed
Market Cap: 12.8B EUR
Section:
 

Relative Value

The Relative Value of one BIM stock under the Base Case scenario is 130.15 EUR. Compared to the current market price of 108.5 EUR, Biomerieux SA is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIM Relative Value
Base Case
130.15 EUR
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
73
vs Industry
33
Median 3Y
3.2
Median 5Y
3.3
Industry
2.3
Forward
3.1
More Details
33.9
P/E
P/E
Price to Earnings
33.9
vs History
12
vs Industry
17
Median 3Y
30.9
Median 5Y
28.5
Industry
22.4
Forward
24.1
More Details
16.2
P/OCF
P/OCF
Price to OCF
16.2
vs History
84
vs Industry
18
Median 3Y
23.2
Median 5Y
21
Industry
14.4
More Details
34.5
P/FCFE
P/FCFE
Price to FCFE
34.5
vs History
77
vs Industry
8
Median 3Y
56.9
Median 5Y
56.9
Industry
21.5
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
52
vs Industry
26
Median 3Y
3.2
Median 5Y
3.3
Industry
2.2
More Details
3.1
EV/S
EV/S
Enterprise Value to Sales
3.1
vs History
69
vs Industry
32
Median 3Y
3.2
Median 5Y
3.3
Industry
2.5
Forward
3
More Details
5.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.5
vs History
71
vs Industry
36
Median 3Y
5.7
Median 5Y
5.9
Industry
5.1
More Details
13
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13
vs History
85
vs Industry
14
Median 3Y
16.3
Median 5Y
15.6
Industry
12
Forward
12.5
More Details
25.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.1
vs History
12
vs Industry
19
Median 3Y
22.5
Median 5Y
21.6
Industry
17.1
Forward
19.2
More Details
16.2
EV/OCF
EV/OCF
Enterprise Value to OCF
16.2
vs History
84
vs Industry
19
Median 3Y
22.8
Median 5Y
21.2
Industry
14.7
More Details
29.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
29.1
vs History
80
vs Industry
11
Median 3Y
57.8
Median 5Y
43.4
Industry
18.8
More Details
2.7
EV/IC
EV/IC
Enterprise Value to IC
2.7
vs History
44
vs Industry
29
Median 3Y
2.6
Median 5Y
2.7
Industry
1.8
More Details

Multiples Across Competitors

BIM Competitors Multiples
Biomerieux SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Biomerieux SA
PAR:BIM
12.8B EUR 3.1 33.9 13 25.1
US
Abbott Laboratories
NYSE:ABT
220.3B USD 5 15.8 20.1 28
US
Intuitive Surgical Inc
NASDAQ:ISRG
199.6B USD 20.8 72.7 55.7 67.9
US
Boston Scientific Corp
NYSE:BSX
140B USD 7.2 50.2 29.4 39.9
US
Stryker Corp
NYSE:SYK
134.8B USD 5.5 45.8 22.4 27.1
IE
Medtronic PLC
NYSE:MDT
126B USD 3.6 26.5 14.9 21.5
DE
Siemens Healthineers AG
XETRA:SHL
50.1B EUR 2.1 23.4 13.2 18.6
US
Becton Dickinson and Co
NYSE:BDX
55.8B USD 2.6 33.2 12.3 21
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD 13.4 54.2 38.9 43.1
US
Edwards Lifesciences Corp
NYSE:EW
49.3B USD 8.4 36 25.7 28.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.5B USD 1.9 16.9 12.6 15.3

See Also

Summary
BIM intrinsic value, competitors valuation, and company profile.
DCF Valuation
BIM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BIM stock valuation using valuation multiples.
Wall Street Estimates
BIM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BIM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.